Myomo (id:287 MYO)
6.03 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/23/2024 7:45:20 PM)
Exchange closed, opens in 13 hours 44 minutes
About Myomo
Market Capitalization 206.22M
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Headquarters (address) |
137 Portland Street Boston 02114 MA United States |
Phone | 617 996 9058 |
Website | https://myomo.com |
Employees | 101 |
Sector | Healthcare |
Industry | Medical Devices |
Ticker | MYO |
Exchange | New York Stock Exchange |
Currency | USD |
52 week range | 2.51 - 6.74 |
Market Capitalization | 206.22M |
P/E trailing | -21.86 |
P/E forward | -122.40 |
Price/Sale | 8.17 |
Price/Book | 19.93 |
Beta | 1.56 |
EPS | 3.00 |
EPS United States (ID:6, base:3382) | 24.33 |